secwatch.observer — SEC 8-K summary
======================================

Issuer:     NutriBand Inc. (NTRB)
CIK:        0001676047
Form:       8-K
Filed at:   2025-12-30T23:59:59+00:00
Accession:  0001213900-25-126650
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutriband sells 90% stake in Pocono Pharma for $5M to EarthVision Bio; retains 10%
--------------------------------------------------------------------------------

- Agreement to sell 90% interest in subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio.
- Nutriband shareholders will retain 10% stake in EarthVision Bio post-acquisition; closing expected Dec 31, 2025.
- Proceeds will fund continued development of AVERSA Fentanyl, an abuse-deterrent opioid patch.
- AVERSA Fentanyl has potential annual US sales estimate of $80M to $200M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676047/000121390025126650/0001213900-25-126650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676047/000121390025126650/ea0271298-8k_nutriband.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-126650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer